These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 20850536

  • 1. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY, Cervera-Cetina R, Tzec-Arjona JL, Ek-Macias L, Sánchez-Burgos G, Ramirez-Sierra MJ, Cruz-Chan JV, VanWynsberghe NR, Dumonteil E.
    Vaccine; 2010 Oct 28; 28(46):7414-9. PubMed ID: 20850536
    [Abstract] [Full Text] [Related]

  • 2. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN, Castelo-Branco MT, Lannes-Vieira J, Gattass CR.
    Exp Parasitol; 1999 Jan 28; 91(1):7-19. PubMed ID: 9920038
    [Abstract] [Full Text] [Related]

  • 3. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
    Chou B, Hiromatsu K, Hisaeda H, Duan X, Imai T, Murata S, Tanaka K, Himeno K.
    Biochem Biophys Res Commun; 2010 Feb 12; 392(3):277-82. PubMed ID: 20059980
    [Abstract] [Full Text] [Related]

  • 4. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X, Yonemitsu Y, Chou B, Yoshida K, Tanaka S, Hasegawa M, Tetsutani K, Ishida H, Himeno K, Hisaeda H.
    Vaccine; 2009 Oct 19; 27(44):6154-9. PubMed ID: 19712768
    [Abstract] [Full Text] [Related]

  • 5. Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi.
    Quijano-Hernández IA, Castro-Barcena A, Vázquez-Chagoyán JC, Bolio-González ME, Ortega-López J, Dumonteil E.
    Vaccine; 2013 Apr 26; 31(18):2246-52. PubMed ID: 23499599
    [Abstract] [Full Text] [Related]

  • 6. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC, Curotto de Lafaille MA, Collet de Araujo Lima GM, de Almeida Abrahamsohn I.
    Cell Immunol; 1996 May 25; 170(1):41-53. PubMed ID: 8660798
    [Abstract] [Full Text] [Related]

  • 7. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
    Barry MA, Wang Q, Jones KM, Heffernan MJ, Buhaya MH, Beaumier CM, Keegan BP, Zhan B, Dumonteil E, Bottazzi ME, Hotez PJ.
    Hum Vaccin Immunother; 2016 Apr 02; 12(4):976-87. PubMed ID: 26890466
    [Abstract] [Full Text] [Related]

  • 8. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP, Sharma D.
    Exp Parasitol; 2000 Apr 02; 94(4):207-16. PubMed ID: 10831388
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA, Vicco MH, Cabrera G, Villar SR, González FB, Roggero EA, Ameloot P, Callewaert N, Pérez AR, Marcipar IS.
    Vaccine; 2015 Mar 03; 33(10):1274-83. PubMed ID: 25625671
    [Abstract] [Full Text] [Related]

  • 10. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.
    Miyahira Y.
    Parasitol Int; 2008 Mar 03; 57(1):38-48. PubMed ID: 17728174
    [Abstract] [Full Text] [Related]

  • 11. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, de Oliveira G, Silvério JC, Machado AV, Lannes-Vieira J, Bruna-Romero O, Gazzinelli RT, dos Santos RR, Soares MB, Rodrigues MM.
    Vaccine; 2009 Sep 18; 27(41):5644-53. PubMed ID: 19635607
    [Abstract] [Full Text] [Related]

  • 12. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease.
    Lopes MF, da Veiga VF, Santos AR, Fonseca ME, DosReis GA.
    J Immunol; 1995 Jan 15; 154(2):744-52. PubMed ID: 7814881
    [Abstract] [Full Text] [Related]

  • 13. From genome screening to creation of vaccine against Trypanosoma cruzi by use of immunoinformatics.
    Teh-Poot C, Tzec-Arjona E, Martínez-Vega P, Ramirez-Sierra MJ, Rosado-Vallado M, Dumonteil E.
    J Infect Dis; 2015 Jan 15; 211(2):258-66. PubMed ID: 25070943
    [Abstract] [Full Text] [Related]

  • 14. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
    Martinez-Campos V, Martinez-Vega P, Ramirez-Sierra MJ, Rosado-Vallado M, Seid CA, Hudspeth EM, Wei J, Liu Z, Kwityn C, Hammond M, Ortega-López J, Zhan B, Hotez PJ, Bottazzi ME, Dumonteil E.
    Vaccine; 2015 Aug 26; 33(36):4505-12. PubMed ID: 26192358
    [Abstract] [Full Text] [Related]

  • 15. B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.
    Cardillo F, Postol E, Nihei J, Aroeira LS, Nomizo A, Mengel J.
    Immunology; 2007 Dec 26; 122(4):584-95. PubMed ID: 17635611
    [Abstract] [Full Text] [Related]

  • 16. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
    Marinho CR, Bastos KR, Sardinha LR, Grisotto MG, Lima MR, Alvarez JM.
    J Parasitol; 2004 Jun 26; 90(3):516-23. PubMed ID: 15270095
    [Abstract] [Full Text] [Related]

  • 17. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
    Guillermo LV, Silva EM, Ribeiro-Gomes FL, De Meis J, Pereira WF, Yagita H, DosReis GA, Lopes MF.
    J Leukoc Biol; 2007 Apr 26; 81(4):942-51. PubMed ID: 17261545
    [Abstract] [Full Text] [Related]

  • 18. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
    Nunes MP, Andrade RM, Lopes MF, DosReis GA.
    J Immunol; 1998 Feb 01; 160(3):1313-9. PubMed ID: 9570549
    [Abstract] [Full Text] [Related]

  • 19. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ, Wrightsman RA, Stryker GA, Manning JE.
    J Immunol; 1997 Jun 01; 158(11):5330-7. PubMed ID: 9164953
    [Abstract] [Full Text] [Related]

  • 20. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S, Garg NJ.
    PLoS Negl Trop Dis; 2010 Aug 10; 4(8):e797. PubMed ID: 20706586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.